10/21/2025
Pluvicto is a breakthrough therapy that delivers a small amount of radiation directly to PSMA+ prostate cancer cells. By targeting only the cancer, Pluvicto helps protect healthy tissue and reduce side effects.
Available at the San Antonio Cancer Center, this treatment offers a new level of care and hope for eligible patients. Learn more:
If you've been diagnosed with PSMA+ metastatic prostate cancer, Pluvicto is aninnovative treatment offering hope.